Literature DB >> 3083911

Glucocorticoid receptors and depression.

L J Whalley, N Borthwick, D Copolov, H Dick, J E Christie, G Fink.   

Abstract

The number of glucocorticoid receptor sites in lymphocytes was estimated and plasma cortisol concentrations measured in 17 depressed patients, 12 patients with chronic schizophrenia, and 31 healthy control subjects. The number of receptor sites was significantly lower in the depressed patients than in either the controls or the patients with chronic schizophrenia, but there were no differences between the groups in the dissociation constants of the glucocorticoid receptors or the plasma cortisol concentrations. When two control subjects were studied intensively over 28 hours a slight diurnal variation in the number of glucocorticoid receptors was detected. The lower numbers of glucocorticoid receptors in the lymphocytes of depressed patients may explain why such patients, who often have hypercortisolaemia, do not show the clinical features of excess production of cortisol.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3083911      PMCID: PMC1339970          DOI: 10.1136/bmj.292.6524.859

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  14 in total

1.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

2.  A simple radioimmunoassay for plasma cortisol.

Authors:  J Seth; L M Brown
Journal:  Clin Chim Acta       Date:  1978-05-16       Impact factor: 3.786

Review 3.  Progesterone receptor and regulation of progestin action in mammalian tissues.

Authors:  O Jänne; K Kontula; R Vihko; P D Feil; C W Bardin
Journal:  Med Biol       Date:  1978-10

4.  Glucocorticoid receptor and effector mechanisms: a comparison of the corticosensitive mouse with the corticoresistant guinea pig.

Authors:  N Kraft; A J Hodgson; J W Funder
Journal:  Endocrinology       Date:  1979-02       Impact factor: 4.736

5.  Reduced level of cellular glucocorticoid receptors in patients with anorexia nervosa.

Authors:  K Kontula; L C Andersson; M Huttunen; R Pelkonen
Journal:  Horm Metab Res       Date:  1982-11       Impact factor: 2.936

6.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06

7.  Insulin receptor status in disease states of man.

Authors:  R S Bar; J Roth
Journal:  Arch Intern Med       Date:  1977-04

8.  Primary cortisol resistance: a familial syndrome and an animal model.

Authors:  G P Chrousos; D L Loriaux; D Brandon; M Tomita; A C Vingerhoeds; G R Merriam; E O Johnson; M B Lipsett
Journal:  J Steroid Biochem       Date:  1983-07       Impact factor: 4.292

9.  Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response.

Authors:  R M Sapolsky; L C Krey; B S McEwen
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

10.  Glucocorticoid receptors in adrenocorticoid disorders.

Authors:  K Kontula; R Pelkonen; L Andersson; A Sivula
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

View more
  11 in total

Review 1.  Dissection of glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis by gene targeting in mice.

Authors:  Gloria Laryea; Lisa Muglia; Melinda Arnett; Louis J Muglia
Journal:  Front Neuroendocrinol       Date:  2014-09-27       Impact factor: 8.606

2.  Antiglucocorticoids as Treatments for Depression : Rationale for Use and Therapeutic Potential.

Authors:  L H Price; R T Malison; C J McDougle; G H Pelton
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

Review 3.  Psychoneuroendocrine research in depression. I. Hormone levels of different neuroendocrine axes and the dexamethasone suppression test.

Authors:  R Rupprecht; K P Lesch
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

4.  Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486.

Authors:  B E Murphy; D Filipini; A M Ghadirian
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

5.  Regulation of corticosteroid receptor gene expression in depression and antidepressant action.

Authors:  N Barden
Journal:  J Psychiatry Neurosci       Date:  1999-01       Impact factor: 6.186

6.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

Review 7.  Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression.

Authors:  Nicholas Barden
Journal:  J Psychiatry Neurosci       Date:  2004-05       Impact factor: 6.186

8.  Crossroads of corticotropin releasing hormone, corticosteroids and monoamines. About a biological interface between stress and depression.

Authors:  H. M. Van Praag
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

9.  Long-term imipramine treatment affects rat brain and pituitary corticosteroid receptors and heat shock proteins levels in a gender-specific manner.

Authors:  I Elaković; J Brkljacić; G Matić
Journal:  J Neural Transm (Vienna)       Date:  2007-03-29       Impact factor: 3.575

10.  Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. Evidence for selective increases of glucocorticoid receptor immunoreactivity in the locus coeruleus and in 5-hydroxytryptamine nerve cell groups of the rostral ventromedial medulla.

Authors:  I Kitayama; A M Janson; A Cintra; K Fuxe; L F Agnati; S O Ogren; A Härfstrand; P Eneroth; J A Gustafsson
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.